Search

Displaying results 5521 - 5530 of 9717 in total
  1. Drug

    D-Asparagine

    go.drugbank.com/drugs/DB03943
    Experimental

    A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase.

  2. Drug

    Leukocyte Platelet Rich Fibrin

    go.drugbank.com/drugs/DB34000
    Experimental

    Leukocyte Platelet Rich Fibrin is a biologic drug.

    Synonyms: L-prf
  3. Drug

    Anti-CD19/CD22 Dual-Target Cord Blood CAR-T Cells

    go.drugbank.com/drugs/DB34005
    Experimental

    Anti-CD19/CD22 Dual-Target Cord Blood CAR-T Cells is a biologic drug.

  4. Drug

    CITY-RBP4

    go.drugbank.com/drugs/DB34001
    Experimental

    CITY-RBP4 is a biologic drug. CITY-RBP4 is under investigation in clinical trial NCT07836452 (A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants).

  5. Drug

    Hemin

    go.drugbank.com/drugs/DB03404
    ApprovedInvestigational

    More specifically, it is protoporphyrin IX containing a ferric iron ion (heme B) with a chloride ligand.

  6. Drug

    Olaparib

    go.drugbank.com/drugs/DB09074
    ApprovedInvestigational

    [L41100, L40908, L43792] PARP inhibitors represent a novel class of anti-cancer therapy and they work by taking advantage of a defect in DNA repair in cancer cells with BRCA mutations and inducing cell … Olaparib is a selective and potent inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, PARP1 and PARP2.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
  7. Drug

    Strontium chloride

    go.drugbank.com/drugs/DB13987
    ApprovedWithdrawn

    Strontium chloride (SrCl2) is a salt of strontium and chloride. … SrCl2 is useful in reducing tooth sensitivity by forming a barrier over microscopic tubules in the dentin containing nerve endings that have become exposed by gum recession [A33167, A33168].

  8. Drug

    Reloxaliase

    go.drugbank.com/drugs/DB15560
    Investigational

    Reloxaliase is a crystalline formulation of oxalate decarboxylase derived from _Bacillus Subtilis_.

  9. Drug

    Indocyanine green

    go.drugbank.com/drugs/DB16024
    ApprovedInvestigationalWithdrawn

    Categories: Compounds used in a research, industrial, or household setting
  10. Drug

    mRNA-3927

    go.drugbank.com/drugs/DB17669
    Investigational

    mRNA-3927 is an investigational mRNA therapy that consists of two mRNAs that encode for the alpha and beta subunits of the mitochondrial enzyme propionyl-CoA carboxylase (PCC) encapsulated within a lipid